Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond

Simple item page
dc.contributor.advisorNovitzky, Nicholasen_ZA
dc.contributor.authorSeth, Yunus Sen_ZA
dc.date.accessioned2014-07-28T13:32:44Z
dc.date.available2014-07-28T13:32:44Z
dc.date.issued2002en_ZA
dc.descriptionIncludes bibliographical references.
dc.description.abstractThe risk of pneumococcal infection post splenectomy is life long so all patients undergoing splenectomy are given polyvalent (23-valent) unconjugated pneumococcal polysaccharide vaccine, preoperatively. The aim of this study was 1. to measure the success of splenectomy at a tertiary institution at 5 years and beyond. 2. To review the incidence of complications peri-operatively and long term. 3. Review the need for possible re-vaccination (as recommended in American and British guidelines and 4. perform a re-appraisal of patients found to be refractory to treatment.en_ZA
dc.identifier.apacitationSeth, Y. S. (2002). <i>Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond</i>. (Thesis). University of Cape Town ,Faculty of Health Sciences ,Division of Clinical Haematology. Retrieved from http://hdl.handle.net/11427/2833en_ZA
dc.identifier.chicagocitationSeth, Yunus S. <i>"Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond."</i> Thesis., University of Cape Town ,Faculty of Health Sciences ,Division of Clinical Haematology, 2002. http://hdl.handle.net/11427/2833en_ZA
dc.identifier.citationSeth, Y. 2002. Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond. University of Cape Town.en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - Seth, Yunus S AB - The risk of pneumococcal infection post splenectomy is life long so all patients undergoing splenectomy are given polyvalent (23-valent) unconjugated pneumococcal polysaccharide vaccine, preoperatively. The aim of this study was 1. to measure the success of splenectomy at a tertiary institution at 5 years and beyond. 2. To review the incidence of complications peri-operatively and long term. 3. Review the need for possible re-vaccination (as recommended in American and British guidelines and 4. perform a re-appraisal of patients found to be refractory to treatment. DA - 2002 DB - OpenUCT DP - University of Cape Town LK - https://open.uct.ac.za PB - University of Cape Town PY - 2002 T1 - Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond TI - Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond UR - http://hdl.handle.net/11427/2833 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/2833
dc.identifier.vancouvercitationSeth YS. Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond. [Thesis]. University of Cape Town ,Faculty of Health Sciences ,Division of Clinical Haematology, 2002 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/2833en_ZA
dc.language.isoengen_ZA
dc.publisher.departmentDivision of Clinical Haematologyen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.subject.otherHaematologyen_ZA
dc.titleReview and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyonden_ZA
dc.typeMaster Thesis
dc.type.qualificationlevelMasters
dc.type.qualificationnameMMeden_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_hsf_2002_seth_ys.pdf
Size:
5.03 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Masters